Associate Scientist IV, Injectable Drug Product Development

This is what you will do: The Associate Scientist IV will join Injectable Drug Product Development group to support the formulation and drug product process development of Alexion’s biotherapeutic candidates. This individual will develop injectable formulations with fit for purpose analytical methods, perform analytical testing, and draft reports for the executed studies. This individual will work independently in a dynamic team environment and routinely collaborate with other members of Injectable Drug Product Development as well as other groups in Product Development and Clinical Supply. You will be responsible for: Execution of formulation screening and stability studies for injectable drug products including proteins, oligonucleotides, and peptides Building expertise in in-use and extractables and leachables assessments Supporting analytical method development and optimization Supporting development and tech transfer of GMP fill finish processes to internal and external manufacturing organizations Writing internal technical reports on the executed studies Assisting in preparation of external regulatory submissions (IND, BLA etc.) for the Alexion product candidates Participate in department meetings and other technical and team building activities You will need to have: Extensive experience in in-use and E&L assessment across different phases of development Extensive experience on developing phase appropriate formulations and fill finish processes Working experience on various injectable dosage forms in vials, prefilled syringes/ cartridges Comprehensive understanding of chemistry and stability, and degradation mechanism of proteins and peptides Excellent interpersonal and communication skills and ability to work in a collaborative setting and adhere to timelines Demonstrated ability to work effectively in a cross-functional settings. Hands-on experience with liquid chromatography methods (e.g. SEC, IEX, HIC) and capillary methods (e.g. iCE, LabChip GXII Touch) Strong knowledge of analytical software (e.g. Empower, JMP) Ability to interpret raw data, organize results and communicate findings to project team and management Understanding of the biotechnology products life cycle and factors impacting product stability. The duties of this role are generally conducted in an lab environment. As is typical of a lab-based role, employees must be able, with or without an accommodation to: lift/carry 15/30 pounds unassisted/assisted; work comfortably in a controlled environment with and around biological, infectious, and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours. We would prefer for you to have: BS or MS degree in Biochemistry, Chemistry, Chemical Engineering or related discipline from an accredited university with with 6 years of experience for MS or 7 years of experience with BS. Knowledge of cGMP and quality guidelines. Date Posted 03-Dec-2025 Closing Date 23-Dec-2025 Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form. For over three decades, patients and their caregivers have been at the center of everything we do. Every day, we are inspired to follow the science and think differently to create better outcomes for them and their families. Our mission is driven by understanding who they are as unique individuals, not solely defined by their diseases. We’re a leading rare disease company with a diversified projects. Our pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into transformative medicines over the past three decades. Today, we continue to push the boundaries of science and deepen our understanding of rare diseases with patient-centricity at the core. This knowledge allows us to innovate and evolve into new areas where needs are unmet and provide an opportunity to help people fully live their best lives.